Medicare Part D Opioid Policies May Incorporate CDC Guidelines
This article was originally published in The Pink Sheet Daily
Executive Summary
CMS notes some success in reducing the number of beneficiaries overusing opioids but proposes additional action for plans to manage access.
You may also be interested in...
Medicare Part D Plans To Control Opioid Access With ‘Lock In’ Program
Addiction prevention legislation empowers Medicare drug plans to restrict prescriber, pharmacy access to opioids for ‘at risk’ beneficiaries.
Insulin Report Revives Senate Finance Committee Push On Drug Pricing Legislation
Report released as soon-to-be committee chair Ron Wyden, D-OR, assembles plans for drug pricing legislation in the new Democratic-controlled Senate.
Medicare Payments Model Experimentation Under Biden Administration ‘Pretty Wide Open’
Former CMS acting administrator Andy Slavitt says agency’s direction during Biden administration depends on nominee, but trust fund’s looming insolvency will be ‘an issue you can’t avoid.’ The president’s priorities around health equity, racial justice and mental health will make their way into CMS policy and demonstration models, Slavitt suggests.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: